BlackRock, Inc. 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-09-09 3:52 pm Sale | 2020-08-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | BlackRock Inc. BLK | 79,095 4.700% | -1,739 (-2.15%) | Filing |